Category: New products
-
IBM, Health Tech, Univ Designing Critical Care Mobile System
23 October 2014. IBM, University of Michigan, and mobile health technology company AirStrip are developing a system to provide real time monitoring and analytics for patients with chronic or critical disorders. The system is being designed to collect data directly from patients and provide early warning initially for hemodynamic decompensation, a type of heart failure…
-
Graphene Sensor Offers Clear Optical Access to Brain Cells
22 October 2014. Engineers at University of Wisconsin in Madison developed an implanted transparent sensor made with graphene that allows for imaging and diagnostics in the brain requiring line-of-sight access. The team led by electrical engineering professor Zhenqiang Ma and biomedical engineering faculty Justin Williams published its findings this week in the journal Nature Communications.…
-
Genomic Data Analysis Service Launches, Hosts Autism Data
20 October 2014. NextCode Health, a start-up informatics company in Cambridge, Massachusetts, unveiled its NextCode Exchange, a shared online genomics database and analysis service for diagnostics and research with sequencing data. The 1 year-old company also is hosting a genomics database of people with autism for online access to researchers. NextCode Health says its databases…
-
Simple 3-D Graphene Construction Process Devised
17 October 2014. Materials scientists at Kyoto University in Japan developed a new process that simplifies the building of three-dimension structures with graphene, a light, strong, conductive material with many industrial and commercial applications. Franklin Kim and Jianli Zou from Kyoto’s Institute for Integrated Cell-Material Sciences published their findings yesterday in the journal Nature Communications…
-
Robot for MRI-Guided Epilepsy Surgery in Development
16 October 2014. Engineers at Vanderbilt University in Nashville are building a robot for epilepsy surgery guided by MRI scans and designed to be less invasive than current surgical methods. The team from Vanderbilt, with colleagues from Georgia Tech and Milwaukee School of Engineering, are demonstrating a prototype of the device this week at the…
-
Experimental Drug Kills Myeloma Cells in Lab, Trial Planned
13 October 2014. Medical researchers at Imperial College London in the U.K. developed an experimental drug that in lab and animal tests kills multiple myeloma cancer cells without the toxic side effects of other cancer drugs. The team led by Imperial medical professor Guido Franzoso published its findings today in the journal Cancer Cell, with…
-
New Coating Material Stops Blood Clots, Bacterial Films
13 October 2014. Engineers and medical researchers at Harvard University developed a material to coat tubes in medical devices that repels blood, preventing clots from forming and reducing the need for blood-thinning drugs. The new material from Harvard’s Wyss Institute for Biologically Inspired Engineering and collaborators at affiliated labs and hospitals is described in an…
-
Stem Cells Engineered to Produce Insulin-Making Cells
9 October 2014. Researchers at Harvard University developed a technique that enables embryonic stem cells to transform into large quantities of insulin-producing beta cells found in the pancreas, a key step in developing a treatment for type 1 diabetes. The team led by biologist Douglas Melton, co-director of the university’s Stem Cell Institute, published its…
-
Mind-Controlled Prosthetic Arm Given Long-Term Test
9 October 2014. Biomedical engineers in Sweden developed and tested for 18 months a prosthetic device connected to a man’s amputated arm that provides electrical signaling with his mind and body. The team of biomedical engineering Ph.D. candidate Max Ortiz-Catalan and professor Bo Håkansson from Chalmers University of Technology and orthopedist Rickard Brånemark of Sahlgrenska…
-
Drug Screening Target Designed for All Ebola Types
8 October 2014. Researchers at University of Utah and Navigen Inc., both in Salt Lake City, designed a synthetic peptide acting like a protein found in all strains of the Ebola virus that can serve as a target when screening for potential drugs to treat patients with the deadly disease. The team led by Utah…